Plantation Sector
Exports lose steam
· August palm oil exports dropped 9.5% m-o-m to 1.316m MT according to MPOB; offset by weak seasonal up-tick in production
· Negative bias in CPO prices may continue near term; but 4QCY09 rebound expected on lower inventory
· Top picks: Wilmar and Kencana Agri
· Malaysian palm oil production forecast cut; CY09F and CY10F CPO price maintained at RM2,300/MT
Astro (RM3.65; Fully Valued; Price Target: RM2.65; ASTR MK)
High churn, low ARPU
· 2QFY10 is in line with our FY1/10F estimate, but is below consensus, hit by highest churn in 4 years
· DCF-based price target tweaked lower to RM2.65
· Maintain Fully Valued. Absence of special dividend may disappoint speculators, with downside risk to consensus earnings.
CB Industrial Product (RM3.15; Fully Valued; Price Target: RM2.80; CBP MK)
Secured RM15.7m new contract from Central America
CBIP’s 100%-owned subsidiary, Modipalm Engineering Sdn Bhd was awarded a palm oil mill contract worth USD4.5m (RM15.7m) by Nacional Agro Industrial S.A. The contract requires CBIP to supply equipment and engineering services for a palm oil mill with an initial capacity of 15MT FFB/hour and expandable to 45MT FFB/hour at Guatemala , Central America .
Eastern and Oriental (RM1.49; Buy; Price Target: RM2.10; EAST MK)
ICSLS issue price fixed at 65sen
E&O's 1-for-2 renounceable rights issue of 8% irredeemable convertible secured loan stock 2009/2019 (ICSLS) has been fixed at 65sen each, as indicated earlier.
Malaysia Airports (RM3.40; Buy; Price Target: RM4.50; MAHB MK)
Yesterday’s off-market trade may involve Khazanah selling down its stake
There are talks that the 55m shares (5% of total MAHB’s shares) traded off-market yesterday morning at RM3.30 per share (3% discount to the last closing price), may likely involve Khazanah Nasional paring down its 72.7% stake. If this is true, it is in line with Khazanah’s intention to gradually reduce its stakes in government-linked companies (GLCs) to improve the stock market liquidity. Khazanah is the Malaysian government’s investment arm.
No comments:
Post a Comment